Owen Grayson Hosseinzadeh, Law Clerk in San Diego, contributed to the drafting of this post.
On November 16, 2022, FDA announced the completion of the first ever pre-market consultation process for a human food made from cultured animal cells, UPSIDE Food's cell-cultured chicken. This is the first such consultation completed by the agency and, while not a formal approval process, means that FDA has no further questions about UPSIDE's conclusions that (1) its production process is safe and (2) its cultured chicken cell products are as safe as comparable foods, like traditionally produced chicken leg meat.
Human food produced using animal cell culture technology is subject to an interagency regulatory framework between FDA's Center for Food Safety & Applied Nutrition (CFSAN) and USDA's Food Safety and Inspection Service (FSIS). Under the agencies' formal agreement, both agencies agreed to a regulatory framework in which CFSAN regulates the initial steps of cell collection, cell banking, and cell differentiation. Once the cells are removed from their sealed growth environments at the harvest stage, FSIS oversees their further processing, labeling, and packaging.
To market its product, UPSIDE will still need to meet additional FDA requirements, such as food facility registration, and will need a grant of inspection from FSIS for the manufacturing establishment. The product itself also must bear a USDA mark of inspection. USDA has yet to issue any guidance or regulations...
Read Full Story:
https://news.google.com/__i/rss/rd/articles/CBMifGh0dHBzOi8vd3d3Lm1vbmRhcS5jb...